• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在高剂量率三维计划阴道残端近距离放射治疗中,我们在分割方案和处方方面处于什么水平?

Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?

作者信息

Rovirosa Angeles, Noorian Faegheh, Cordoba Sofia, León Francesc, Lancellotta Valentina, Tagliaferri Luca, Herrreros Antonio

机构信息

Fonaments Clinics Department, Universitat de Barcelona, Barcelona, Spain.

Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain.

出版信息

J Contemp Brachytherapy. 2024 Oct;16(5):352-361. doi: 10.5114/jcb.2024.144183. Epub 2024 Oct 16.

DOI:10.5114/jcb.2024.144183
PMID:39719951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11664800/
Abstract

PURPOSE

Currently, there are many schedules for exclusive vaginal cuff brachytherapy (VCB). In 3D treatment planning for VCB dosimetry, parameters have not been analyzed. The aim of this study was to compare the most common schedules using dose-volume histogram metrics.

MATERIAL AND METHODS

Three different computed tomography (CT) studies for vaginal cylinders of 3.5 cm, 3 cm, and 2.5 cm were performed. Clinical target volume (CTV) was delineated for 3 cm and 4 cm of vaginal length. Twelve schedules were analyzed obtaining overall vaginal surface dose (Gy) (EQD α/β = 10 and α/β = 3), overall D CTV (Gy), and overall D for organs at risk (OARs), such as vagina, rectum, sigmoid, rectum, and bladder. Prescription at 5 mm from the applicator surface and at the surface were analyzed for each case.

RESULTS

The overall vaginal surface dose and dose to CTV varied widely among the different schedules, and CTV delineation was necessary in case of surface prescription. The applicator diameter of 3.5 cm showed the best dosimetry results for vaginal surface dose. The overall D OARs' doses changed in the different CT studies.

CONCLUSIONS

This dosimetry study allows for better selection of fractionation schedules, and helps to unify treatments among centers. Prospective studies are needed to establish the best schedule and CTV length in each patient using clinical data, such as late toxicity and relapses.

摘要

目的

目前,有多种用于单纯阴道袖状近距离放射治疗(VCB)的方案。在VCB剂量测定的三维治疗计划中,尚未对参数进行分析。本研究的目的是使用剂量体积直方图指标比较最常见的方案。

材料与方法

对3.5厘米、3厘米和2.5厘米的阴道圆柱体进行了三项不同的计算机断层扫描(CT)研究。对3厘米和4厘米的阴道长度勾画临床靶区(CTV)。分析了12种方案,得出整个阴道表面剂量(Gy)(等效剂量α/β = 10和α/β = 3)、整个CTV的剂量(Gy)以及对危及器官(OARs)如阴道、直肠、乙状结肠、直肠和膀胱的整个剂量。对每种情况分析了距施源器表面5毫米处和表面处的处方剂量。

结果

不同方案之间整个阴道表面剂量和CTV剂量差异很大,在表面处方的情况下,勾画CTV是必要的。3.5厘米的施源器直径在阴道表面剂量方面显示出最佳的剂量测定结果。不同CT研究中OARs的整个剂量有所变化。

结论

这项剂量测定研究有助于更好地选择分割方案,并有助于各中心统一治疗。需要进行前瞻性研究,以利用临床数据(如晚期毒性和复发情况)为每位患者确定最佳方案和CTV长度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/81167ec31057/JCB-16-54997-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/aee375e5d899/JCB-16-54997-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/b0fd97555ae5/JCB-16-54997-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/81167ec31057/JCB-16-54997-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/aee375e5d899/JCB-16-54997-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/b0fd97555ae5/JCB-16-54997-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f386/11664800/81167ec31057/JCB-16-54997-g003.jpg

相似文献

1
Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?在高剂量率三维计划阴道残端近距离放射治疗中,我们在分割方案和处方方面处于什么水平?
J Contemp Brachytherapy. 2024 Oct;16(5):352-361. doi: 10.5114/jcb.2024.144183. Epub 2024 Oct 16.
2
Are 7.5 Gy×2 fractions more efficient than 6 Gy×3 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis.7.5 Gy×2 分次是否优于 6 Gy×3 分次在单纯术后子宫内膜癌近距离放疗中的应用?一项临床和剂量学分析。
Radiother Oncol. 2023 Dec;189:109909. doi: 10.1016/j.radonc.2023.109909. Epub 2023 Sep 11.
3
Dosimetric evaluation of different cylinder diameters in three-dimensional vaginal brachytherapy for early-stage endometrial cancer.不同直径施源器在早期子宫内膜癌三维阴道近距离放疗中的剂量学评估。
J Cancer Res Clin Oncol. 2024 Nov 25;150(12):510. doi: 10.1007/s00432-024-05994-x.
4
Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.在宫颈癌腔内近距离放疗中使用羟丙基甲基纤维素进行直肠分离:一种创新方法。
J Contemp Brachytherapy. 2016 Oct;8(5):399-403. doi: 10.5114/jcb.2016.62951. Epub 2016 Oct 11.
5
Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.用于医学上无法手术的子宫内膜癌的Rotte‘Y’施源器高剂量率近距离放射治疗的二维与三维剂量测定比较
Technol Cancer Res Treat. 2006 Oct;5(5):521-7. doi: 10.1177/153303460600500509.
6
High-dose-rate brachytherapy in uterine cervix carcinoma: a comparison of dosimetry and clinical outcomes among three fractionation schedules.子宫颈癌的高剂量率近距离放射治疗:三种分割方案的剂量测定与临床结果比较
Front Oncol. 2024 Jul 12;14:1366323. doi: 10.3389/fonc.2024.1366323. eCollection 2024.
7
Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction at 2 cm of vagina.子宫内膜癌术后阴道晚期G2毒性与阴道2 cm处相当于每次分割2 Gy的68 Gy剂量相关。
J Contemp Brachytherapy. 2018 Feb;10(1):40-46. doi: 10.5114/jcb.2018.74140. Epub 2018 Feb 28.
8
Applicator-guided proton therapy versus multichannel brachytherapy for vaginal vault irradiation.施源器引导质子治疗与多通道近距离放疗在阴道穹窿照射中的应用比较。
Phys Eng Sci Med. 2023 Sep;46(3):1287-1295. doi: 10.1007/s13246-023-01297-6. Epub 2023 Jul 5.
9
Investigating the Influence of Body Mass Index on Organs at Risk Doses for Adjuvant High-Dose-Rate Vaginal Cuff Brachytherapy in Patients with Early-Stage Endometrial Carcinoma: A Single-Center Experience.探讨体重指数对早期子宫内膜癌患者辅助高剂量率阴道残端近距离放疗中危及器官剂量的影响:单中心经验
Diagnostics (Basel). 2025 Mar 21;15(7):795. doi: 10.3390/diagnostics15070795.
10
Dosimetric impact of bladder filling on organs at risk with barium contrast in the small bowel for adjuvant vaginal cuff brachytherapy.膀胱充盈对辅助性阴道残端近距离放疗中使用钡剂造影剂时小肠危险器官的剂量学影响。
J Contemp Brachytherapy. 2021 Dec;13(6):655-662. doi: 10.5114/jcb.2021.112117. Epub 2021 Dec 30.

本文引用的文献

1
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial.早期子宫内膜癌短程辅助阴道穹窿近距离放疗较标准治疗的财务效益:SAVE 试验
Pract Radiat Oncol. 2024 Nov-Dec;14(6):e500-e506. doi: 10.1016/j.prro.2024.07.006. Epub 2024 Sep 13.
2
Impact of Vaginal Dilator Use and 68 Gy EQD2 Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer.阴道扩张器使用及68 Gy等效均匀剂量限制对术后子宫内膜癌外照射后行近距离放疗时阴道并发症的影响
J Pers Med. 2024 Aug 8;14(8):838. doi: 10.3390/jpm14080838.
3
Are 7.5 Gy×2 fractions more efficient than 6 Gy×3 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis.
7.5 Gy×2 分次是否优于 6 Gy×3 分次在单纯术后子宫内膜癌近距离放疗中的应用?一项临床和剂量学分析。
Radiother Oncol. 2023 Dec;189:109909. doi: 10.1016/j.radonc.2023.109909. Epub 2023 Sep 11.
4
Changes in receipt of adjuvant brachytherapy for endometrial cancer patients before and after affordable care act: The impact of Medicaid expansion.《平价医疗法案》实施前后子宫内膜癌患者辅助近距离放射治疗的接受情况变化:医疗补助扩大的影响
J Contemp Brachytherapy. 2023 Jun;15(3):206-211. doi: 10.5114/jcb.2023.127838. Epub 2023 Jun 1.
5
Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.近距离放射治疗在子宫内膜癌术后管理中的作用:欧洲经验丰富的放射肿瘤学家的决策分析
Cancers (Basel). 2022 Feb 11;14(4):906. doi: 10.3390/cancers14040906.
6
Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis.阴道限制用于减少子宫内膜癌术后近距离放疗后G2期晚期阴道并发症的初步结果:一项前瞻性分析
Clin Transl Oncol. 2022 May;24(5):875-881. doi: 10.1007/s12094-021-02737-z. Epub 2021 Dec 1.
7
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.磁共振引导自适应近距离放疗在局部晚期宫颈癌中的应用(EMBRACE-I):一项多中心前瞻性队列研究。
Lancet Oncol. 2021 Apr;22(4):538-547. doi: 10.1016/S1470-2045(20)30753-1.
8
Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.西班牙近距离放疗协会和西班牙妇科肿瘤学会阴道穹窿近距离放疗的共识和建议。
Clin Transl Oncol. 2021 Jun;23(6):1193-1200. doi: 10.1007/s12094-020-02510-8. Epub 2020 Nov 25.
9
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.PORTEC-4a 试验中用于指导子宫内膜癌辅助治疗的分子综合风险特征的近距离治疗质量保证。
Radiother Oncol. 2021 Feb;155:160-166. doi: 10.1016/j.radonc.2020.10.038. Epub 2020 Nov 5.
10
Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients.宫颈癌和子宫内膜癌患者阴道残端近距离放疗计划的剂量学评估
J Contemp Brachytherapy. 2020 Jun;12(3):248-251. doi: 10.5114/jcb.2020.96865. Epub 2020 Jun 30.